Efficacy and safety
Showing 1 - 25 of >10,000
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Sarcopenia Trial (Whey postbiotics derived from kefir lactic acid bacteria, Placebo powder)
Not yet recruiting
- Sarcopenia
- Whey postbiotics derived from kefir lactic acid bacteria
- Placebo powder
- (no location specified)
Nov 21, 2023
Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)
Not yet recruiting
- Immune Tolerance
- +2 more
- Tacrolimus or Cyclosporine A
-
Tianjin, Tianjin, ChinaTianjin First Central Hospital
Nov 23, 2023
Psoriasis Trial in Lahore (Apremilast 30mg)
Completed
- Psoriasis
- Apremilast 30mg
-
Lahore, Punjab, PakistanGhurki Hospital
Sep 5, 2023
Magnetically-controlled Capsule Gastroscopy for Postoperative
Not yet recruiting
- Evaluation,Efficacy,Safety
-
Shanghai, ChinaDepartments of Gastroenterology and Clinical Laboratory, Shangha
Sep 7, 2023
Chronic Rhinosinusitis, Postoperative Care Trial in Taichung (Xylitol Powder, Salt Powder)
Completed
- Chronic Rhinosinusitis
- Postoperative Care
- Xylitol Powder
- Salt Powder
-
Taichung, None Selected, TaiwanTaichung Veterans General Hospital
Oct 25, 2023
To Compare Efficacy of Dexmedetomidine in Bilateral Quadratus Lumborum vs Lumbar Epidural Blocks on Analgesia After Major Lower
Not yet recruiting
- To Compare Efficacy of Dexmedetomidine in Bilateral Quadratus Lumborum vs Lumbar Epidural Blocks on Analgesia After Major Lower Abdominal Surgery
- nerve block
- (no location specified)
Nov 10, 2023
Efficacy, Team, Adverse Reaction to Drug Trial in Chongqing (Sertraline)
Completed
- Efficacy, Team
- Adverse Reaction to Drug
-
Chongqing, Chongqing, ChinaThe First Affiliated Hospital of Chongqing Medical University
Nov 8, 2023
Huntington Disease Trial (NestaCell®)
Not yet recruiting
- Huntington Disease
- NestaCell®
- (no location specified)
Oct 18, 2023
Sarcopenia Trial (whey protein isolate, isolated soy protein, )
Not yet recruiting
- Sarcopenia
- whey protein isolate
- +2 more
- (no location specified)
May 22, 2023
Hypertension Trial (Placebo, lorundrostat Dose 1, lorundrostat Dose 2)
Not yet recruiting
- Hypertension
- Placebo
- +2 more
- (no location specified)
Nov 22, 2023
Essential Hypertension, Primary Hypertension Trial (Amicomed®, Digital Placebo, Usual Care)
Not yet recruiting
- Essential Hypertension
- Primary Hypertension
- Amicomed®
- +2 more
- (no location specified)
Oct 19, 2023
Transthyroxin Amyloidosis Cardiomyopathy Trial in Hangzhou (YOLT-201)
Recruiting
- Transthyroxin Amyloidosis Cardiomyopathy
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, Zhejiang University School of Med
Oct 7, 2023
Glabellar Frown Lines Trial (PROTOXIN)
Not yet recruiting
- Glabellar Frown Lines
- PROTOXIN
- (no location specified)
Nov 8, 2023
Dexmedetomidine, Bupivacaine, Supraclavicular Brachial Plexus Block Trial in Kafr Ash Shaykh (bupivacaine and dexmedetomidine.,
Not yet recruiting
- Dexmedetomidine
- +2 more
- bupivacaine and dexmedetomidine.
- +2 more
-
Kafr Ash Shaykh, Kafrelsheikh, EgyptKafrelsheikh University
Aug 26, 2023
Psoriasis Trial in Shanghai (LZM012, Secukinumab)
Recruiting
- Psoriasis
- LZM012
- Secukinumab
-
Shanghai, Shanghai, ChinaHuashan Hospital
Oct 29, 2023
Rosacea Trial (Barrier Renew)
Not yet recruiting
- Rosacea
- Barrier Renew
- (no location specified)
Jul 18, 2023
Safety of Suppressive Therapy With DALBAVANCINE in Device
Completed
- Prosthesis-related Infections
- Dalbavancin Injection
-
Tourcoing, FranceCH Tourcoing
Oct 12, 2023
Crow's Feet Trial in Seoul (DKB-119)
Active, not recruiting
- Crow's Feet
- DKB-119
-
Seoul, Korea, Republic ofChungang-University Hospital
Aug 28, 2023